GCE |
MWCNTs |
MWCNTs-Cys-AuNPs |
Signal amplification, reproducibility, stability, sensitivity and cost-effective |
Direct |
DPH |
6.7 × 10−9 M |
2 × 10−8–7.5 × 10−4 M |
[72] |
GCE |
MWCNTs |
MWCNT-Pt-luminol |
ECL signal, sensitivity, fast analysis, stability and specificity |
Label-free |
CA19-9 |
0.00004 U mL−1
|
0.0001–10.0 U mL−1
|
[63] |
GCW |
MWCNTs |
MWCNTs-Au |
Signal amplification, selectivity, stability and low-cost |
Direct |
Bisphenol A |
0.083 μM |
0.25–100 μM |
[61] |
GCE |
HCNTs |
HCNTs-Polyallylamine hydrochloride (PAH)-CdSe QDs |
Signal amplification, increased surface area, stability, sensitivity and excellent specificity |
Direct |
DA |
0.2 × 10−9 M |
1.0 × 10−9–2.0 × 10−5 M |
[87] |
GCE |
Magnetic nanofibers/CNHs |
CNHs |
Excellent electrical conductivity, biocompatibility, large surface areas, variable porosity, amplified ECL, large antibody, acceptable precision, low detection limit, reproducibility and stability |
Label-free |
AFB1 |
0.02 ng mL−1
|
0.05–200 ng mL−1
|
[81] |
GCE |
MWCNTs |
MWCNT-Pt-luminol |
ECL signal, fast analysis, stability, reproducibility and specificity |
Label-free |
CA19-9 |
0.00004 U mL−1
|
0.0001–10.0 U mL−1
|
[85] |
GCE |
MWCNTs |
nanoCo-MWCNTs |
Sensitivity, economical and practical applications |
Direct |
Glucose |
50 nM |
0.5–600 μM |
[86] |
GCE |
MWCNTs |
MWCNTs-GO-Thi-Au |
Enhancing ECL, high sensitivity and good selectivity |
Enzymatic |
Cholesterol |
50 nM |
0.15–828 µM |
[73] |
GCE |
MWCNTs |
GO/MWCNTs-COOH/Au@CeO2
|
High sensitivity, repeatability, accelerated electrons transfer, long-term stability and wide linear range |
Label-free |
CEA |
0.02 ng mL−1
|
0.05–100 ng mL−1
|
[74] |
ITO |
MWCNTs |
ABEI/GNDs/chitosan/COOH-MWCNTs |
Strong and stable ECL signal, selectivity, stability and extremely high sensitivity |
Label-free |
NT-proBNP |
3.86 fg mL−1
|
0.01–100 pg mL−1
|
[71] |
GCE |
MWCNTs |
rGO/MWCNTs/AuNPs |
Enhanced ECL signal intensity, high sensitivity, good reproducibility and repeatability |
Direct |
DA |
0.067 µM |
0.20–70 µM |
[75] |
GCE |
GO |
MWCNTs-GO-Thi-Au |
Enhanced ECL, high sensitivity and excellent stability |
Enzymatic |
Cholesterol |
50 nM |
0.15–828 µM |
[73] |
GCE |
GO |
GO/MWCNTs-COOH/Au@CeO2
|
High sensitivity, accelerated electron transfer, selectivity and wide linear range |
Label-free |
CEA |
0.02 ng mL−1
|
0.05–100 ng mL−1
|
[74] |
GCE |
GO |
nanoFe3O4@GO |
Good conductivity, magnetism, reproducibility and regeneration |
Label-free |
CA19-9 |
0.0005 U mL−1
|
0.001–5 U mL−1
|
[79] |
GCE |
rGO |
rGO/MWCNTs/AuNPs |
Enhanced ECL signal intensity, high sensitivity and repeatability |
Direct |
DA |
0.067 µM |
0.20–70 µM |
[75] |
GCE |
rGO |
Fe3O4 (Au-FrGO) |
Increased ECL, specific surface area, biocompatibility, sensitive response, excellent stability and selectivity |
Label-free |
CEA |
3.28 fg mL−1
|
0.01 pg mL−1–10 ng mL−1
|
[9] |
GCE |
rGO |
(RGO)/Fe3O4/CdSe |
Sensitivity, stability, excellent reproducibility and selectivity |
Label-free |
IL-6 |
0.65 pg mL−1
|
0.002–20 ng mL−1
|
[10] |
GCE |
GO |
PtNFs/GO/GODx |
High electrocatalytic activity, enhanced luminol ECL, reliability, high surface area, linear range and low detection limit |
Direct |
Glucose |
2.8 μM |
5–80 μM |
[94] |
QDs-SPE |
CNOs |
AuNPs@CNOs |
High ECL, increased effective surface area for capturing and binding of antibodies, improved electron transmission rate, enhanced photon capture and highly sensitive |
Label-free |
β2M |
1 fg mL−1
|
1 fg mL−1–100 ng mL−1
|
[7] |
GCE |
SWCNH |
Aptamer/SWCNH |
Quenching of ECL, sensitive, selective, simple, time-saving and cost-effective |
Label-free |
Adenosine triphosphate (ATP) |
1 nM |
5 nM–500 μM |
[95] |
GCE |
OMCs |
luminol-AgNPs@OMC |
Fast, sensitive, specific, stable and reliable |
Label-free |
AFB1 |
50 fg mL−1
|
0.1 pg mL−1–50 ng mL−1
|
[62] |